Ergoteles’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-103,997
Closed -$652K 1897
2022
Q4
$652K Sell
103,997
-180,163
-63% -$1.13M 0.02% 607
2022
Q3
$995K Sell
284,160
-126,240
-31% -$442K 0.04% 486
2022
Q2
$1.21M Buy
+410,400
New +$1.21M 0.04% 464
2021
Q1
Sell
-98,400
Closed -$565K 1127
2020
Q4
$565K Buy
+98,400
New +$565K 0.02% 431